Welcome to LookChem.com Sign In|Join Free

CAS

  • or

401502-08-7

Post Buying Request

401502-08-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

401502-08-7 Usage

Chemical class

Piperazine derivative

Structural features

4-bromophenoxy group
Methyl substituent

Usage

Intermediate for the synthesis of pharmaceutical drugs

Pharmacological properties

Antidepressant potential
Anxiolytic potential
Anti-inflammatory potential

Receptor interaction

Dopamine D3 receptor ligand

Potential applications

Treatment of neurological disorders
Treatment of psychiatric disorders

Check Digit Verification of cas no

The CAS Registry Mumber 401502-08-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,1,5,0 and 2 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 401502-08:
(8*4)+(7*0)+(6*1)+(5*5)+(4*0)+(3*2)+(2*0)+(1*8)=77
77 % 10 = 7
So 401502-08-7 is a valid CAS Registry Number.

401502-08-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[2-(4-BROMOPHENOXY)ETHYL]-4-METHYLPIPERAZINE

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:401502-08-7 SDS

401502-08-7Downstream Products

401502-08-7Relevant articles and documents

BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD

-

Page/Page column 236, (2020/07/14)

The present disclosure provides BET inhibitors of the formula: wherein the variables are defined herein, as well as pharmaceutical compositions thereof. The present disclosure also provides methods of treating a patient comprising administering a bromo- and extra-terminal (BET) domain inhibitor for the treatment of FSHD which modulates DUX4 expression. In some embodiments, the present methods comprise using one or more BET inhibitors as a therapeutic agent for the treatment of FSHD patients including patients who are being treated with one or more palliative treatments such as therapy and/or agents which lead to increased muscle mass.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 401502-08-7